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Is There a Connection between Carbon
Monoxide Exposure and Hypertension?
by David G. Penney* and John W. Howleyt
Exposuretoarbonmonoxideinoursocietyisafrequentoccurrence,fromautoexhaust,induialeffluents,andcigarette
smoke, andtakesplaceoverawiderangeofconcentrations. IthasbeensuggestedthatchronicCOinhalationmayalter
bloodpreure,evenpossiblyprovkinghypertension byacftingaloneorincombationwithotherenir l stressos
Somestudies 1mmning theresponsetoCOexposurehavereporteddecreasesinbloodpressure,whereasothers havefound
increasesornochange. Bloodpressureinlong-termcigarettesmokersisgenerflydecreasedrlativetononsnokers,albeit
aslight decrease. Thestrengthofthisfindingissonewhatcloudedbytheeffectofthelowerbodyweightinsmokers. The
increasesinbloodpressureobservedacutely withsmokingaremainlyduetonicotine. Chronically, thehypertensiveac-
tionofnicotine islargely offsetbythehypotensive actionofCQ Several studiessupport thenotionthatenvironmental
COexposureorsmokingacceleratesorexacerbateshypertensioninsomepeople. Ithasbeenassertedthatchronic CO
exposureincreasesthe developmentofatherosclerotic disease; however, convincingevidence fromanimalexperiments
is lacking. Nevertheless, CO may elevate plasma cholesterol and does appear to enhance atherosclerosis when serum
cholesterol isgreatlyelevatedbydiet. Usingtheborderlinehypertensiverat,ananimalmodelreputedtohaveincreased
sensitivity toenvironmental stimuli, we found noevidence to suggest a provocatory role for CO in thedevelopment of
hypertension; instead, COexposure produced hypotension. Onthewhole, thehumanandanimal literature, aswell as
ourstudies, failtosupportthehypothesisthatlong-termCOexposureiscapableofprovokinganincreaseinbloodpressur,
even in borderline hypertensive or sensitive individuals.
Introduction
Carbon monoxide is aproductoftheincompletecombustion
of carbonaceous substances. Human exposure to CO in our
society isfrequentandtakesplace over awide rangeofconcen-
trations. Itderivesmainlyfrom autoexhaust, industrial effluents,
andcigarette smoke. Inunderdevelopedcountries, fumes from
heating and cooking equipment are far more important CO
sources. CO levels in the open air may reach 50 to 100 ppm, or
even higher onoccasion, and in certain locations may result in
carboxyhemoglobin (COHb) saturations of 5 to 12% or above
(1). Cigarette smoke contains 30,000 to 50,000 ppm CO and,
depending uponsmoking frequency andtheextentofinhalation
ofthe smoke, can produce up to 12 to 14% COHb (2).
Hypertension is amajorhealthproblem inthe western world,
with approximately 20% ofthe population showing borderline
to severe highblood pressure. Hypertension is awell-recognized
riskfactor for coronary heartdisease, heartfailure, andstroke.
Despitethe enormous human exposure toCO, fewstudieshave
examined thepossible contributory role ofCO in the develop-
ment of hypertension. Based upon the studies that have been
done, it would appear that CO is not an important factor in
hypertension inthegeneralpopulation. Nonetheless, there may
be individuals within the population who display heightened
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sensitivity toCOintermsofbloodpressure. Forexample, those
individuals withmildlyelevatedbloodpressure (i.e., borderline
hypertensives) areusuallyyoungerandtendtohaveanelevated
cardiac output. This contrasts with people with established
hypertension, forwhomelevatedtotalperipheralresistanceisthe
rule. Borderline hypertensives are frequently those people in
whichonlyoneparentshowsfrankhypertension. Theyarealso
reported to have reducedbaroreceptor sensitivity compared to
normotensives (3), as well as elevated plasma catecholamines
and reninactivity (4), suggesting somedegreeofneuralhyper-
activity.
Thefollowingdiscussion reviewstheeffectsofCOexposure
onbloodpressure, bothwhenadministeredasapuregasadded
to air and as a component of cigarette smoke. Because ath-
erosclerosismayalsocontributetoproducinghypertension, the
possible role of CO inhalation in the development ofathero-
sclerosis iscritically assessed. Bothanimal andhuman studies
areexamined. Finally,thesummaryresultsofarecentstudywith
theborderlinehypertensive rat(BHR)arepresented, anexperi-
mentinwhichthehypothesisthatchronicCOexposuremaypro-
vokehypertensionwastested. Foradiscussionofthegeneralcar-
diovasculareffectsofCO, several otherreviews shouldbe con-
sulted (5-8).
Carbon Monoxideand Blood Pressure
The response to CO in the Sprague-Dawley rat has been
thoroughly studiedbyPenneyandhiscollaborators(6-16). The
responseconsistsofsystemic arterialhypotension(Table 1) andPENNEYAND HOWLEY
Table 1. Blood pressure response tochronic carbon monoxide exposure.
CO concen-
Speciesa tration, ppm Duration Response Reference
Rat (SHR) 500 27 days Decrease (16)
Rat (S-D) 500 27-42 days Decrease (15)
Rat (Dahl,+NaCI) 500 63 days Increase (17)
Rabbit 1500 10+ weeks Increase (20)
Rabbit 100 2500 hr Increase (19)
Goat 160-200 2 weeks Nochange (21)
Dog 1000 I year No change (22)
Monkey (11.2% COHb) 8 months Nochange (23)
Human (12% COHb) 8 days Nochange (24)
Human ? (foundry) Months-years Slight increase (25)
'SHR, spontaneously hypertensive; S-D, Sprague-Dawley.
reduced systemic vascular resistance. This occurs even though
stroke volume and heart rate are elevated (9). Thechanges are
observedatCOHblevelsaslowas5%. Atthesametime, polycy-
themia, expanded blood volume, andcardiac hypertrophy deve-
lopinresponsetoCOhypoxia(10-12) inadose-dependentman-
ner (13,14) (e.g., polycythemia is apparent even after chronic
exposureto 100ppmCO). COdoesnotproducepulmonaryvas-
cularhypertension. TherapideliminationofCO, asoccursupon
returntoroomair, causesatransientelevationofvascularresis-
tance and blood pressure (1-2 days), while stroke volume and
heart rate return to normal values (15). Reduced arterial blood
pressurehasalsorecentlybeendemonstratedinthespontaneous-
ly hypertensive rat(SHR)during chronicexposuretoCO (16).
Incontrast,astudywiththeDahlsalt-sensitiveratfedadietcon-
taining8% NaClfoundthat500ppmCOexposurefor62to63days
enhanceddevelopmentofsystemichypertension(17).Itwassug-
gestedthatthiscameaboutastheresultofCOraisingcardiacout-
put at the same time that high dietary sodium was elevating
peripheralresistance. Thisexplanation,however, failstorecog-
nizethefactthatCO lowers peripheral vascular resistance (9).
Other common airpollutants such as ozone and sulfurdioxide
do not producehypertension in this rat model (18), suggesting
thattheeffectofCOisspecific, oratleastthatitisduetohypoxia.
Truhautetal. (19)foundthatthebloodpressureofrabbits was
higher following 100 ppm CO exposure for 2500 hr. A similar
resultwasobtainedbyKubota(20) inrabbitsafterinhalationof
1500ppmCOfor3hreachdayformanyweeks. Inthelattercase,
theelevatedbloodpressurefailed torenormalizeafterexposure
when CO treatment exceeded 7 weeks.
Incontrast, Jamesetal. (21) sawnosignificantchangeinpeak
left ventricular pressureand total peripheral resistance in con-
scious goats maintained at20% COHb for2 weeks. Likewise,
Lillehei andassociates (22)foundnormalbloodpressure indogs
gradually acclimatized to 1000ppmCOfor6to8hrperdayfor
1 year. Nochangeinbloodpressurewasobservedincynomolgus
monkeys after 8 months at 11.2% COHb (23).
As in rats, acute CO exposure has been shown to decrease
peripheral resistance inhumans(26). Thisprobably resultsfrom
the relaxation ofvascularsmooth muscleinvolving mechanisms
postulated to be active inthe local control ofblood flow (e.g.,
adenosine release), and/or the inhibition ofreflex sympathetic
vasoconstrictor fibersusuallyactivatedbyhypoxia. COmayalso
actto resetthebaroreceptorreflex ortoalterreflexgain, acon-
dition found in borderline hypertensives (3). In addition, CO
could act to modify neural output long term, as by increasing
catecholamineoutflow, which it is known to doacutely (6).
During chronic CO exposure, Klausen et al. (24) found no
changes in systolic and diastolic blood pressure in resting men
maintained at 12% COHb for 8 days. The former pressure in-
creasedandthelatterfellrelativeto menworkingwhilebreathing
airwhenthe meninhalingCOalsoworked. In acute exposures,
Aronow etal. (27) failed tofindchanges insystolicanddiastolic
arterial blood pressures inpatientsacutely inhaling 150 ppmCO.
Incontrast, thesystolicanddiastolicblood pressuresoffoundry
workersexposed toCO(andothergases) werefoundtobeslight-
lyhigherthanthoseofunexposed workerswhen ageandsmok-
inghabits weretakenintoconsideration(25). A 1980epidemio-
logic studyattemptedtorelateelevatedurbanCOconcentration
and the greater incidenceofhypertension in city dwellers who
werecloserelativesofvillagedwellers(28). Unfortunately,other
factorspresentintheurbanenvironmentsuch asnoise, crowding,
etc., may also act to alterblood pressure.
In summary, theblood pressure responsetochronic exposure
to pure CO gas as reported in a number of animal and a few
human studies is mixed, with some studies finding increases,
somedecreases, and some no change.
CigaretteSmokingand BloodPressure
AcuteExposure
Cigarette smoking has been shown to acutely raise blood
pressureandheart rateand todecreasethe skin temperature of
thefingersandtoes(29) (Table2). Herxheimeretal. (30) found
that while inhalation ofsmoke from filter tip cigarettes and of
nicotine aerosol produced increases in heart rate and blood
pressure in healthy subjects, inhalations from nicotine-free
cigarettes (i.e., dried lettuce leaves) and ofaerosol propellant
alonehad noeffect onthecirculation. Similarobservationshave
beenmadebyothers (31), suggestingthatnicotine, notCO, isthe
active ingredient in cigarette smoke.
luble2. The blood pressure response tocigarettesmoking.
Response Subjects Condition Reference
Increase Normotensive Acute (29)
Increase Normotensive Acute (32)
Increase Hypertensive Acute (49)
No changea Normotensive Acute (30)
No changea Normotensive,
CHDb Acute (31)
Increase Hypertensive Acute and chronic (50)
Decrease Normotensive Chronic (43)
Nochange Normotensive Chronic (34)
Decrease Normotensive Chronic (35)
Decrease Normotensive Chronic (36)
Decrease Normotensive Chronic (37)
Decrease Normotensive Chronic (38)
Nochange Normotensive Chronic (41,42)
Decrease Normotensive Chronic (39)
Decrease Normotensive Chronic (40)
Decrease Pregnant Chronic (45)
Decrease Normotensive Chronic (46)
Decrease Normotensive Chronic (44)
Nochange Normotensive Chronic (47)
Decrease Normotensive Chronic (48)
Nochange Hypertensive Chronic (51)
Malignanthypertension Hypertensive Chronic (52)
Malignanthypertension Hypertensive Chronic (53)
Acceleratedhypertension Hypertensive Chronic (54)
aNicotine-freecigarettes.
bCHD, coronary heartdisease.
192CO AND HYPERTENSION
Aziz etal. (32) delineated twoquitedifferentgroupsofsub-
jectsamong smokersandnonsmokers. Normoreactors showed
modest increases inbloodpressure (6-10mm Hg)andheartrate
(6-7 beats/min) after smoking two cigarettes; hyperreactors
showed responsestwotothreetimesaslarge. Thiswasalsotrue
to a lesser extent with respect to urinary total free cate-
cholamines. Nicotine infusion was found to elevate blood
pressure and cardiac output in deoxycorticoserone acetate
(DOCA)-salttreated, uninephectomized rats, butfailedtodoso
in rats ingesting a normal salt diet (33).
Chronic Exposure
Dawber et al. (34) found no association of either blood
pressure or relative body weight with cigarette smoking in the
Framingham study population (Table 2). Thomas (35) found
slightly lowerdiastolicbloodpressuresandhigherheartratesin
smokers than in nonsmokers. Blackburn and co-workers (36)
found lower blood pressures and higher heart rates among
smokers than nonsmokers and a tendency for smokers to be
leanerthannonsmokers. Incontrast, Bronte-Stewart(37)found
no significant difference in blood pressure in smokers and
nonsmokersofCapetown, South Africa, although smokerstend-
ed to have a slightly lower blood pressure.
Smokers in a Tecumseh, Michigan, population had lower
diastolicbloodpressures, weighedless,andhadfasterheartrates
thannonsmokers (38). Jenkins etal. (39) foundthatsmokers in
the Western Collaborative Group Study had lowerblood pres-
suresandweighedlessthannonsmokers. Andrusandco-workers
(40) reported that both systolic and diastolic blood pressures
were negatively correlated with smoking inastudycarried out
in King City, California.
Reidetal. (41,42) found lowerbloodpressures in smokers in
both America and Great Britain, but this could be largely ac-
counted for by the lower body weights among the smokers.
Lower blood pressure was also found in a Finnish study of
cigarette smokers (43). In this study the smokers were leaner
thanthe nonsmokers. This blood pressure difference was con-
firmedinasurveyof5249middle-aged malecigarettesmokers
in Scandinavia (44). Thedifference could notbeexplained by
group differences in age, body weight, or physical fitness. An
association of lower blood pressure and smoking has been
reported in pregnant women (45).
Seltzer (46) reported lower mean blood pressure and body
weight forcurrentcigarette smokersascomparedtononsmokers
and former smokers. In an analysis of changes in the Fram-
inghampopulation relatedtothecessationofsmoking, Gordon
etal. (47)foundtherewereonlytrivialchangesinbloodpressure
inbothdirections, butthatmengainedweightafterquitting. In
astudy of10,000Israeli men(48), it was revealedthatsmokers
weighedlessandhadlowersystolicanddiastolicbloodpressures.
Ballantyneetal. (51) found norelationship betweencigarette
consumption and either systolic or diastolic blood pressure in
hypertensive patients. Incontrast, Freestone and Ramsay (50)
found that mean blood pressure was substantially lower in
hypertensives afterabstaining fromcigarettes andcoffee over-
night. Smoking twocigarettes (3.4mgnicotine) elevatedblood
pressureby 10/8 mmHg,butforonly 15min, whereasdrinking
coffee (200 mg caffeine) elevated blood pressureby up to 10/7
mm Hg for I to2hrs. Similarresults wereobtainedinthiazide-
treatedpatients. BaerandRadichevich (49)agreedandextend-
edthesefindings, reportingacutely increasedheartrate, blood
pressure, plasmaadrenalcorticotropic hormone, cortisol, and
catecholaminelevelsin 19hypertensivepatientsaftersmoking.
AccordingtoIslesetal. (52), thechanceofahypertensivepa-
tientwhosmokeshavingthemalignantphaseofhypertensionis
5-foldthatofahypertensive patient whodoes not. Bloxham et
al. (53) also suggest a relationship between cigarette smoking
andmalignanthypertension. ElliotandSimpson (54) foundan
excessofacceleratedhypertensioninhypertensivepatientswho
smoked. There was no difference in the smoking or drinking
habitsofthepatientswithbenignhypertensionandthosewithac-
celeratedhypertension.
Basedondatafromalargenumberofstudies, itisclearthat,
on the average in normotensive subjects, cigarette smoking
lowers blood pressure, albeit slightly, as well as body weight
(55). Cigarettesmokingalsoincreasesheartrate. Itisnotclear
whetherthelowerbloodpressureisduetodecreasedbodyfator
whether it is due to an independent effect of smoking. The
tendency forex-smokers togainweight indicates thatthebody
weightdifferenceisnotinborn, butisaneffectofsmoking. The
acute increases in blood pressure seen with smoking are pro-
bably duetonicotine. Overthelong term, thehypertensive ef-
fectsofnicotineareprobablylargelyoffsetbythehypotensiveef-
fects ofCO.
In hypertensive subjects, in contrast, cigarette smoking ap-
pears toelevatebloodpressure. The findingby Azizetal. (32)
oftwoquitedifferentgroupswhenexposedacutely tocigarette
smoke, normoreactorsandhyperreactors, isconsistentwiththis
notion. AssuggestedbyElliotandSimpson(54),althoughsmok-
ingcannotbeconsideredtheprimary causeofhypertension, it
may accelerate the condition. Thus, smoking may predispose
some individualstohypertension, possiblythosewithborderline
hypertensionorthosewithspecial sensitivitiestoenvironmen-
tal stress.
Carbon Monoxide and Atherogenesis
Epidemiologicstudieshavelinkedcigarettesmokingwithan
increased incidenceofatherosclerosisofthe coronary arteries
and other majorblood vessels. It has been alleged that, ofthe
manyconstituentsoftobaccosmoke, COisthemajorcausative
agent, itsmodeofactionbeingtoincreasethedepositionoflip-
poproteincholesterol inthearterialwall. Othershavepointedto
other components ofcigarette smoke as the probable culprit.
Wald&etal. (56), forexample, inastudyof1085volunteerswork-
ing inCopenhagen, reportedthatsmokersinwhomCOHbwas
greater than 5% were 21 times more likely to develop ath-
erosclerosisthanwerethoseinwhomCOHbwaslessthan3%.
TheproductionofatherosclerosisbyCOcouldcontributetothe
long-term alteration ofblood pressure, i.e., contribute to the
development ofhypertension.
ReviewedbelowareanumberofanimalCO-exposurestudies
relatingtoatherosclerosisthatwereconductedwiththepuregas.
Wehavechosennottoevaluatestudiescarriedoutwithtobacco
smoke. Theliteratureclearlypointsoutthefactthatspeciesvary
widely with respect to their susceptibitily to induction of
atherosclerosis in the presence ofCO, with or without added
dietary cholesterol, and that the results of a number ofearly
studies carriedoutinalessthanidealfashionhavesincehad to
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be setaside. Severalolderreviews maybeconsultedonthistopic
(57-60).
Astrup etal. (61) reportedthatthedegreeofaorticatheroma-
tosis and the content of total cholesterol in aortic tissue was
significandlyhigherinrabbitsexposedto200to350ppmCOand
fed 2% cholesterol than in controls (Table 3). In later ex-
periments (75), theeffects were foundtobe greaterwith inter-
mittent than with continuous CO exposure. It should be noted
thatthe serumcholesterollevelsattainedinthese studieswerefar
higher than seen in most humans (800-2000 mg/dL). Even in
CO-exposed rabbits (11% COHb) fed anormaldietfor3months,
aorticchanges weresupposedlyidentifiedbylightmicroscopyas
atherosclerosis, which were not seen in controls (62). No ma-
croscopic intimal changes were seen, however. Kjeldsen et al.
(75,76), using the electron microscope, reportedlocal areas of
partial or total necrosis ofmyofibrils, intimal and subintimal
edema, and fibrosis in rabbits fed anormaldietandexposed to
180ppmCOcontinuouslyfor2 weeks. Ahigherincidenceofin-
timal changes was found in rabbits exposed to 180ppm CO for
4 hror morethan inthose inwhichtheCOexposurewasshorter
or involvedalowerCOconcentration(64). Noneofthese stud-
ies, however, were carried out in a blind manner.
Inotherstudies, mildatheroscleroticlesions wereobservedin
theaortaandthecoronaryandrenal arteriesofadultrabbitsex-
posed to 300 to 500 ppm CO for 4 to 6months; additionof2%
cholesterol tothedietcausedmore severeandwidespreadlesions
(63). Unfortunately, thestudydidnotincludeadequatecontrols.
Davies etal. (65) confirmedthisfindingin rabbitsfed2% chol-
esterol for 10weeks and in whichtheCOHbconcentration was
20% duringtheexposureperiods. TheCO exposuredid notfur-
ther elevate plasma or aortic cholesterol. In contrast, when
noncholesterol-fed rabbits wereexposed to200, 2000, or 4000
ppm CO repeatedly for briefperiods, no evidenceofcoronary
or aortic vessel disease could be demonstrated (66).
Armitageetal. (67)foundthatCO(10% COHb)exposurefor
6 hr per day had no enhancing effect in normocholesterolemic
whitecarneaupigeons; however, inhypercholesterolemicbirds,
theseverityofcoronaryarteryatherosclerosis wassignificantly
Table3. A role forcarbon monoxide inatherosclerosis?
CO concen- Added dietary
Atherosclerosis Subjects trations, ppm cholesterol Reference
Yes Rabbit 200-350 Yes (61)
Yes Rabbit ( 1% COHb) No (62)
Yes Rabbit 300-500 No and
yes (63)
Yes Rabbit 1808 No (64)
Yes Rabbit (20% COHb)a Yes (65)
No Rabbit 200,2000,40008 No (66)
No Pigeon (10% COHb)' No (67)
Yes Pigeon (10% COHb)a Yes (67)
Yes Pigeon 150' Yes (68)
No Pig 1008 Yes (69)
Yes Monkey 100-3008 Yes (70)
Yes Monkey 250 No (71)
No Monkey No (72)
dog (3240%COHb)
baboon
rodents
No Monkey (21% COHb)a Yes (73)
No Monkey 200-4008 No (74)
alntermittent.
greaterinbirdsexposedtoCO.Turneretal.(68),alsousingwhite
caneaupigeons,foundthattheincidenceandseverityofcoronary
arterydiseasewasassociatedwithintermittentexposureto 150
ppmCOorhigherwhenthebirdswerefed0.5%and1.0%dietary
cholesterol. With 1.0% dietary cholesterol the response was
relatedtothecloseofCO. AlthoughAstrupetal. (61)reported
thatexposuretolowlevelsofCOincreasedaortictotalcholesterol
contentinrabbitsfedahighcholesteroldiet,itwaslaterfoundthat
thismayhaveresultedfromdifferencesinserumcholesterolbet-
weentheexposedandnonexposedgroups(77).
Anumberofstudies, reviewedbyTopping(78), suggestthat
CO is capable ofdamaging the endothelium ofarteries. This
couldfacilitatethedepositionofcholesterol intheintimaandex-
acerbatethedevelopmentofatherosclerosis. Forexample, en-
dothelial permeability is increasedby CO (79). Parving et al.
(80) reported that CO exposure increased the transcapillary
escape route ofradiolabeled albumin from the blood. The in
vitroperfusionofhumancoronaryarterieswithbloodcontain-
ing 15% COHbwasfoundtoincreasethevessel walluptakeof
[3H]cholesterol (81). This is consistent with the findings of
others (80,82).
Marshall and Hess (83) found that exposure ofminipigs to
160, 185, and420ppmCOfor4hrdailyledtoincreasedplatelet
aggregation. Increasedplatelet stickiness was noted in rabbits
exposedto400ppmCO(84). Whilelightmicroscopyrevealed
nochanges inthearterial wall, scanning electronmicroscopic
examination showedadhesionsofshape-changedplateletsonthe
arterialendothelium, in somecasesafteronly asingle4-hrex-
posure toCO. Incontrast, COisreported toinhibittherelease
ofadenosinediphesphateand serotoninbyplatelets(85), actions
that slowplateletaggregation (86).
At concentrations of200 to 300 ppm, CO was found to ag-
gravate atherosclerosis in the coronary arteries of squirrel
monkeysfedacholesterol-containingdietfor7months; this was
notthecase,however,intheaorta(70).Afteronly2weeksofex-
posureto250ppmCO,Thomsen(71)reportedseeingendothelial
edemaandotherultrastructuralchangesindicativeofatheros-
clerotic vasculardisease inmonkey coronary arteries. In con-
trasttotheseobservations, Sultzer(69) foundthatthethickness
ofcoronary arteryintimal lesions wasnotincreased inpigs ex-
posed to 100ppmCOfor4monthsandfed anatherogenicdiet.
Theodore and his associates (72) detected no atheromatous
changes inthe aortas ofmonkeys, baboons, dogs, and rodents
exposedtoCO(32-40% COHb) for 168daysandfedstandard
chow. No aortic or coronary atherosclerosis was detected in
cynomolgus monkeys intermittently exposed to CO (21 %
COHbmaximum)for 14months, eitherafterbeingfedanormal
diet or when fed a dietcontaining added cholesterol (73). In a
likefashion,Bingandhiscolleagues(74)foundnoassociation
betweenCOexposureanddevelopmentofatherosclerosis inthe
same spicies ofmonkey intermittently exposed to 200 to 400
ppmCO for 12 months.
Despitetheclaimsofearlystudies, thereremainsnoconvin-
cing evidence that chronic CO exposure increases the risk of
developingclinicallysignificantatheroscleroticdisease(58,60),
although in some experimental models CO tends to elevate
serumcholesterol(59). Onlywhenserumcholesterolisartifici-
ally and greatly elevatedbydietary supplementationdoes CO
exposure appear toenhanceatherosclerosis. Theevidence for
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CO-induced atherogenesis in normocholesterolemic pigeons,
swine, and primates is particularly unconvincing. In the rabbit,
however, CO exposure alone may stimulate atherosclerosis.
EffectsofCarbon Monoxide Exposure
in a Model System
To examine the effects of chronic CO exposure on blood
pressure, and particularly with regard to individuals having
borderlinehighblood pressureand/or anenhanced sensitivity to
environmental stress, an appropriate animal model was sought.
TheBHR, arelatively newanimal, waschosen forthis purpose.
The BHR is the F1 progeny of an SHR female and a normoten-
siveWistarKyoto (WKY) male. The BHR is reported to be sen-
sitive to various environmental stimuli such as shock, cold,
restraint, anddietary salt (87), rapidlydeveloping frankarterial
hypertensioncompared tounstressed littermates. It was the in-
tentofthestudy todeterminewhetherchronic CO exposure, with
orwithoutthe presence ofanother stressor(i.e., salt ingestion),
wouldprovoke hypertension in this species, and once provoked
whether hypertension would persist (88).
Threedifferent age groups ofmale BHR were used. Systolic
blood pressure and heart rate measurements werebegun at 62,
83, and 115 daysofage, using thetail-cuffmethod (9). The study
design is shown in Figure 1. The three study groups were
designated as "young," "intermediate," and "old" BHR. Begin-
ning at 62, 103, and 172 days ofage, the rats in each study were
randomly assigned to one of two groups, one group thereafter
receiving powdered chow containing 8.8% NaCl, the other
receiving standardchow (0.8% NaCl). At 80, 122, and 201 days
of age, each of the high-sodium groups and the low-sodium
groups were again randomly assigned, one-halffor exposure to
CO, the otherhalfto remain in room air (air). Thereafter, each
study contained four groups; a) no salt/air, b) no salt/CO, c)
salt/air, andd) salt/CO. Each group ineach study contained six
to eight rats. CO exposure and the high sodium diet were ter-
minated 28 to 31 days later. The rats remained in room air until
sacrifice.
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FIGURE 1. Designofthestudyexaminingthe responses ofyoung, intermediate
age, andoldborderlinehypertensive rats(BHR) tochronic500 ppmcarbon
monoxide exposure, ahighsalt(&8.%)diet, and acombinationofchronic 500
ppmcarbon monoxide exposureand ahighsalt(8.89%)diet. Theheavy hori-
zontal lines indicateperiods beforeandaftersalt/carbon monoxide treatment.
Therats, housed inplastic shoe-boxcages, werecontinuous-
ly exposedto500ppmCO(COHb = 40%) inlarge, transparent
plastic bags inflated by an air-CO mixture (88). The flow rate
through each bag was approximately 25 L/min to ensure rapid
removal ofwaste gases. CO concentration was monitored by a
Beckmaninfrared gasanalyzer. Hematocrit wasdetermined in
triplicate by the microhematocrit method.
Ingestion ofthe high-sodium diet increased water consump-
tion by 50 to 80% in the old study group before CO exposure.
The rate ofweightgain was slowed in the intermediate and old
BHR, whilebodyweightgainofthetwonosaltgroupsincreas-
edsteadily. Thisindicatesthatsaltingestionat 11-foldthenormal
amountconstituted asignificantstressontheanimals, although
lowerbodyweightgainofthesalt-treated ratsmayhavereflected
lowerfoodconsumption duetothe poorpalatibility ofthe high
saltdiet. CO exposure had no effect on body weight gain.
Systolic blood pressure increased modestly with age in both
theyoung and intermediate groups, buttended toremaincons-
tantintheoldgroup(Fig. 2). Theadditionof8percentNaClto
thediethadnosignigicanteffectonbloodpressureinanyofthe
threestudygroups, withoneexception(intermediateagesalt/air
group). Inthis instancehowever, bloodpressure was notelevated
during an earlier period of salt treatment. Exposure to CO
resulted in significant decreases in blood pressure in all three
study groups. The changes were ofabout the same magnitude
regardless ofage(i.e., 10-16mm Hg)andwerenotmodifiedby
thepresenceofsalt. Bloodpressure recovered tocontrol levels
within 1 to2weeksafterterminating COexposure. Exposureto
COresulted innolongtermalterationofbloodpressureafterex-
posure to CO, with or without salt, with one exception (old no
salt/COgroup). Inthis casetheelevationofbloodpressurewas
statistically significant(p < 0.05), butsmall (8 mmHg). Neither
salt norCO, separately or incombination, had a significant ef-
fectonheart rateinanyofthethreestudy groups, eitherduring
or after CO and /or salt treatment.
Hematocrit was increased from approximately 53 to 70% in
all threestudygroupsbyexposureto500ppmCOfor4weeks.
With one exception, the presence of salt did not modify the
polycythemic response to CO. In the young group, hematocrit
was2.7% lower(p <0.05) intheratsreceiving saltandCOthan
in rats only exposed to CO. Hematocrit returned to or slightly
below the control valuesafterterminating CO exposure.
Insummary,thisstudydemonstratedthatbloodpressureisnot
elevatedduringorafterchronicCOexposureintheBHR,withor
withoutconcurrentsalttreatment. AgeatthetimeofCOandsalt
treatmentdoesnotalterthebloodpressureresponse.COexposure
significantlylowersbloodpressureduringtheperiodofexposure.
OurresultscontrastsharplywiththoseofShiotsukaetal. (17),
whichwasdiscussedabove. Theyreportedthat500ppmCOex-
posure for 62 to 63 days enhanced development of systemic
hypertension inthe Dahl salt-sensitive ratfed adietcontaining
8% NaCl. Thedegreeofhypotension wefoundintheBHRwas
similartothatseeninpreviousstudieswiththeSprague-Dawley
rat(89)andtheSHR(16). Theremaybemajorphysiological dif-
ferences betweenthe Dahl ratandthe BHR.
Thefailuretoobserveanelevationinbloodpressureinratsin-
gesting thehigh-sodiumdietisinexplicablebecausetheparents
wereprocuredfromthesamebreedingunit, andtheBHRtested
wereoftheappropriateageandreceivedexactlythesamesodium
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FIGURE 2. Systolic blood pressure changes (relative to an untreated control
group)ofyoung, intermediateage, andoldborderlinehypertensiverats(BHR)
treated with a high salt (8.8%) diet, expoced to 500 ppm carbon monoxide
(CO) forapproximately 30days, andallowed torecover in roomairwhile in-
gesting alow salt (0.8%) diet. Control istheperiod before saltandCOtreat-
ment; salt/no salt - CO/air is the period when salt and CO treatment took
place; post salt/no salt - CO/air is the period when salt and COtreatments
werediscontinued. Ageduring eachmeasurementperiod isgivenbeloweach
panel. Notethattherewasnocontrol periodfortheyounggroupbecausethey
weretoosmall atthattimetoobtain measurements withthetailcuff. Numbers
below the vertical barsarecontrol values ±SEofthemean. Compared tothe
control value: (+)p < 0.05; (++)p<0.0l..
supplement as in previous studies reporting increased blood
pressure (90,91). The method ofblood pressure measurement
was identicaltothat usedinprevious studies. Thehigh-sodium
dietappearedtobestressful as indicatedby the increased water
uptake and reduction in body weightgain.
Conclusions
Animal studiesexaminingtheacuteandchronicresponses to
COexposureyieldnoclear-cutpattern intermsofarterial blood
pressure. The paucity of good chronic human studies is not
helpful inthis regard. Ingeneral, cigarette smokinglowersblood
pressureslightly innormotensivesubjects, whereasthereissome
evidencethatCOraisesbloodpressureinhypertensivesand/or
accelerates the development of malignant hypertension. A
careful examination ofthe available animal studies reveals no
convincingevidencethatCOexposureinnormocholesterolemic
subjects increases the risk of atherosclerotic disease. Thus,
atherogenic-related hypertension is probably not a function of
long-term CO exposure.
Finally, byusingamodelsystemreputedtohaveincreasedsen-
sitivity toenvironmental stimuli, wehavefoundnoevidenceto
suggest a provocatory role for CO in the development of im-
mediateorpersistent hypertension. Instead, COexposurepro-
ducedmarkedhypotension, followedby normal bloodpressure
uponterminatingCOexposure. Asfarashumanhypertension is
concerned, theBHRdatafailtosupportthehypothesisthatlong-
term CO exposure can provoke an increase in blood pressure,
even inborderline hypertensive and/orsensitive individuals. In
most regards, our results are consistent with the animal and
humanstudiesreviewed, boththosecarriedoutwithpureCOgas
and those with cigarette smoke, in showing some degree of
systemicarterial hypotension. Theexceptionstothis statement
are the studies ofhumanhypertensives, where cigarette smok-
ing appears to exacerbate high blood pressure (49,50,52-54).
Thiscouldbeduetothefactthatcigarette smokecontainsmany
othersubstancesinadditiontoCOtowhichsomepeoplemaybe
especially sensitive.
ThecollectionofdataontheBHRratweremadepossiblebyaresearchgrant
from St. John Hospital and Medical Center, Detroit, Michigan. The BHR rats
weregenerouslydonated by RonaldCox, MiamiUniversity, Oxford, Ohio. We
thank Roman Skikun fortechnical assistance and Ann Marie Blenc for help in
carrying out the literature search.
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